This inventor holds 1 USPTO granted patent. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Chuan Gao: Innovator in Nucleic Acid Technology
Introduction
Chuan Gao is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of nucleic acid technology, particularly through his innovative patent work. His research focuses on enhancing the stability and efficiency of mRNA, which is crucial for various applications in biotechnology and medicine.
Latest Patents
Chuan Gao holds a patent for a "C6'-substituted locked nucleic acid-modified cap analog and use thereof." This invention provides a cap analog that improves the stability of mRNA and enhances its translation efficiency. The implications of this patent are vast, as it can lead to advancements in therapeutic applications and genetic research.
Career Highlights
Chuan Gao is currently employed at Hangzhou Tianlong Pharmaceutical Co., Ltd. His role at the company allows him to apply his innovative ideas in a practical setting, contributing to the development of new pharmaceutical products. His expertise in nucleic acid technology positions him as a valuable asset in the industry.
Collaborations
Chuan Gao collaborates with fellow researcher Honglei Zhang. Their partnership fosters a productive environment for innovation and research, leading to advancements in their respective fields.
Conclusion
Chuan Gao's contributions to nucleic acid technology through his patent work exemplify the importance of innovation in biotechnology. His efforts not only enhance scientific understanding but also pave the way for future advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile